|
|
| Research article summary (published 16 Aug 2009): |
Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases.
Full Abstract
The skin protects us from water loss and mechanical damage. The surface-exposed epidermis, a self-renewing stratified squamous epithelium composed of several layers of keratinocytes, is most important in the barrier defense against these challenges. Endogenous and exogenous proteases such as kallikreins, matriptase, caspases, cathepsins, and proteases derived from microorganisms are important in the desquamation process of the stratum corneum and are able to activate and inactivate defense molecules in human epidermis. Protease inhibitors such as like LEKTI, elafin, SLPI, SERPINs, and cystatins regulate their proteolytic activity and contribute to the integrity and protective barrier function of the skin. Changes in the proteolytic balance of the skin can result in inflammation, which leads to the typical clinical signs of redness, scaling, and itching. This review summarizes the current knowledge of how proteases, their inhibitors, and their target proteins, including filaggrin, protease-activated receptors, and corneodesmosin, contribute to the pathophysiology of inflammation of the skin and highlight their role in common inflammatory skin diseases such as atopic dermatitis, rosacea, and psoriasis.
Author information
Author/s: Meyer-Hoffert, Ulf (U);
Affiliation: Department of Dermatology, University Hospital Schleswig-Holstein, D-24105, Kiel, Germany. umeyerhoffert(-atsign-)dermatology.uni-kiel.de
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal: Archivum immunologiae et therapiae experimentalis (Arch Immunol Ther Exp (Warsz)), published in Switzerland. (Language: eng)
Reference: -2009 Sep-Oct; vol 57 (issue 5) : pp 345-54
Dates: Created 2009/08/26; Completed 2009/10/21;
PMID: 19688185, status: MEDLINE (last retrieval date: 10/21/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Protease-antiprotease imbalance in inflammatory diseases in the lung.
30 Jul 2005 - Calculating proton uptake/release and binding free energy taking into account ionization and conformation changes induced by protein-inhibitor association: application to plasmepsin, cathepsin D and endothiapepsin-pepstatin complexes.
13 Aug 2004 - Hybrid protease inhibitors for pest and pathogen control--a functional cost for the fusion partners?
20 Apr 2008 - [Treatment of burn surfaces by proteinases: mathematical description of an enzyme distribution]
30 Dec 2002 - Refolding of recombinant proteins.
30 Dec 1989 - Proteases - proteases inhibitors: a local cellular information system.
30 Dec 1983 - rd1 Mouse retina shows an imbalance in the activity of cysteine protease cathepsins and their endogenous inhibitor cystatin C.
28 Feb 2008 - Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis.
4 Feb 2008 - Biomarkers in COPD: time for a deep breath.
30 Jul 2007 - Characterization and function of intracellular proteinases and proteinase inhibitors from yeast.
30 Dec 1976
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.